{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T08:42:18Z","timestamp":1761986538640,"version":"build-2065373602"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.jaip.2020.01.008","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T11:50:26Z","timestamp":1579089026000},"page":"1387-1393.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials"],"prefix":"10.1016","volume":"8","author":[{"given":"Susanne","family":"Halken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erkka","family":"Valovirta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Nolte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veronica","family":"Hulstr\u00f8m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.","family":"Blaiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2020.01.008_bib1","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1080\/00325481.2017.1308208","article-title":"Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma","volume":"129","author":"Brunton","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaip.2020.01.008_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2010.09.034","article-title":"Allergen immunotherapy: a practice parameter third update","volume":"127","author":"Cox","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib3","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2008.06.003","article-title":"The diagnosis and management of rhinitis: an updated practice parameter","volume":"122","author":"Wallace","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/all.13317","article-title":"EAACI Guidelines on Allergen Immunotherapy: allergic rhinoconjunctivitis","volume":"73","author":"Roberts","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.008_bib5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1398-9995.2011.02589.x","article-title":"Immunological mechanisms of allergen-specific immunotherapy","volume":"66","author":"Jutel","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.008_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jaci.2010.08.030","article-title":"Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study","volume":"126","author":"Marogna","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.jaci.2011.12.973","article-title":"SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial","volume":"129","author":"Durham","year":"2012","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13601-015-0057-8","article-title":"Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score","volume":"5","author":"Didier","year":"2015","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaip.2020.01.008_bib9","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1398-9995.2007.01451.x","article-title":"Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study","volume":"62","author":"Jacobsen","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2020.01.008_bib10","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1067\/mai.2002.121317","article-title":"Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study)","volume":"109","author":"Moller","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib11","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jaci.2004.07.012","article-title":"Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis","volume":"114","author":"Novembre","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib13","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jaci.2015.04.045","article-title":"Randomized controlled trial of primary prevention of atopy using house dust mite allergen oral immunotherapy in early childhood","volume":"136","author":"Zolkipli","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/pai.12807","article-title":"EAACI Guidelines on Allergen Immunotherapy: prevention of allergy","volume":"28","author":"Halken","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib15","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1399-3038.2007.00556.x","article-title":"Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children","volume":"18","author":"Ibanez","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib17","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib19","series-title":"Delivery technologies for biopharmaceuticals: peptides, proteins, nucleic acids and vaccines","first-page":"395","article-title":"Grazax\u00ae: an oromucosal vaccine for treating grass pollen allergy with immunotherapy","author":"Lundegaard","year":"2009"},{"key":"10.1016\/j.jaip.2020.01.008_bib20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000479693","article-title":"Bioavailability of house dust mite allergens in sublingual allergy tablets is highly dependent on the formulation","volume":"174","author":"Ohashi-Doi","year":"2017","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2478\/v10007-011-0020-8","article-title":"The technologies used for developing orally disintegrating tablets: a review","volume":"61","author":"Badgujar","year":"2011","journal-title":"Acta Pharm"},{"key":"10.1016\/j.jaip.2020.01.008_bib22","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.clinthera.2019.02.008","article-title":"The importance of tablet formulation on allergen release kinetics and efficiency: comparison of freeze-dried and compressed grass pollen sublingual allergy immunotherapy tablet formulations","volume":"41","author":"Lund","year":"2019","journal-title":"Clin Ther"},{"year":"2014","series-title":"Grastek (Timothy grass pollen allergen extract tablet for sublingual use) [package insert]","key":"10.1016\/j.jaip.2020.01.008_bib23"},{"key":"10.1016\/j.jaip.2020.01.008_bib25","first-page":"982","article-title":"Administration and burden of subcutaneous immunotherapy for allergic rhinitis in U.S. and Canadian clinical practice","volume":"21","author":"Blume","year":"2015","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.jaip.2020.01.008_bib27","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2016.06.044","article-title":"Efficacy of house dust mite SLIT-tablet in North American adolescents and adults in a randomized, placebo-controlled trial","volume":"138","author":"Nolte","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib28","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1080\/00325481.2017.1302306","article-title":"A\u00a0practical guide to the sublingual immunotherapy tablet adverse event profile: implications for clinical practice","volume":"129","author":"Bernstein","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/j.jaip.2020.01.008_bib29","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1517\/14740338.2015.1017468","article-title":"Safety and tolerability of 5-grass pollen tablet sublingual immunotherapy: pooled analysis and clinical review","volume":"14","author":"Didier","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.jaip.2020.01.008_bib30","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/j.jaci.2014.01.030","article-title":"Esophageal hypereosinophilia induced by grass sublingual immunotherapy","volume":"133","author":"Antico","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1159\/000355161","article-title":"Induction of eosinophilic esophagitis by sublingual pollen immunotherapy","volume":"7","author":"Miehlke","year":"2013","journal-title":"Case Rep Gastroenterol"},{"key":"10.1016\/j.jaip.2020.01.008_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/pai.12660","article-title":"The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a paediatric assessment","volume":"28","author":"Rodr\u00edguez del R\u00edo","year":"2017","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib33","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2015.2840","article-title":"Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis","volume":"175","author":"Di Bona","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jaip.2020.01.008_bib34","first-page":"84","article-title":"Epinephrine use in clinical trials of sublingual immunotherapy tablets","volume":"5","author":"Nolte","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bib35","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/ACI.0b013e32834c229e","article-title":"Risk factors for systemic reactions to allergen immunotherapy","volume":"11","author":"Iglesias-Cadarso","year":"2011","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bibE1","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1399-3038.2007.00556.x","article-title":"Safety of specific sublingual immunotherapy with SQ standardized grass allergen tablets in children","volume":"18","author":"Ibanez","year":"2007","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bibE2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jaci.2008.10.044","article-title":"Safety and efficacy in children of an SQ-standardized grass allergen tablet for sublingual immunotherapy","volume":"123","author":"Bufe","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bibE3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jaci.2010.11.034","article-title":"Efficacy and safety of timothy grass allergy immunotherapy tablets in North American children and adolescents","volume":"127","author":"Blaiss","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bibE4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.anai.2013.11.018","article-title":"Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial","volume":"112","author":"Maloney","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2020.01.008_bibE5","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaci.2017.06.014","article-title":"Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy","volume":"141","author":"Valovirta","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820300477?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219820300477?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:21:08Z","timestamp":1761974468000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219820300477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213219820300477"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.008","relation":{},"ISSN":["2213-2198"],"issn-type":[{"type":"print","value":"2213-2198"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of Timothy Grass Sublingual Immunotherapy Tablet in Children: Pooled Analyses of Clinical Trials","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2020.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}